Going with the flow
Diabetic Foot Ulcer care is a journey.
We’re with you,
every step of the way.
Moving Diabetic Foot Ulcer prevention and treatment forward
Diabetes increases the risk of serious complications like Diabetic Foot Ulcers (DFUs) in two ways: damaging nerves in the feet and reducing the quality of blood circulation to the lower limbs. This combination decreases the ability to sense pain, often causes inflammation and impairs wound healing.
We’re CompedicaTM – a UK-based medical device technology company dedicated to developing innovative product solutions that harness the healing power of blood flow to help healthcare professionals prevent and treat DFUs. We keep Diabetic patients protected, mobile and moving forward on their journey, one step at a time.
Full closure of 80%
of chronic wounds
in compliant patients,
in as little as 12 weeks1
Take an active stance against Diabetic Foot Ulcers
Foot health should be a priority for all Diabetic patients and we’re here to help. Learn more about our insoles that can be your first line of defence against DFUs and our wearable, prescription-only medical device, OptiPulse® Active Therapy System2 that enhances your DFU treatment while keeping you mobile.
Harness the power of perfusion within DFU treatment plans
Diminished blood flow and persistent inflammation, particularly in chronic DFUs, are obstacles to wound healing1. Our OptiPulse™ active therapy system can help break through those treatment barriers. OptiPulse™ integrates a plantar compression pump into a protective, Prescription-only, wearable medical device that keeps the blood pumping, the pressure off and and patients engaged in and compliant with your treatment plan.
We’re driven by a singular purpose – supporting the health of individuals from the ground up
Each foot has 28 bones and more than 30 joints, all of which are subjected to wear-and-tear on a daily basis. Layer in a medical diagnosis of diabetes, or arthritis of the foot or ankle, and protecting the health of an individual’s feet becomes even more of a priority. Our team is dedicated to developing innovative product solutions that harness the power of blood flow as one of the gateways to good health.
1. A Single Arm Prospective Feasibility Study Evaluating Wound Closure with a Unique Device that Provides Intermittent Plantar Compression and Offloading in the Treatment of Non-Healing Diabetic Foot Ulcers (2021).
2. RX-Only US FDA-cleared Class II | CE Class 2A Medical Device
Disclaimer: The products referenced on this website are intended for the prevention and/or treatment of Diabetic Foot Ulcers (DFUs). Although certain products may have received marketing authorization in select jurisdictions, they remain in the pre-commercial stage with some currently being evaluated in randomized controlled trials to further establish their safety and effectiveness compared to standard of care treatments.
Information provided on this site is intended for healthcare professionals, patients and caregivers, and business stakeholders. It is not a substitute for medical advice, diagnosis, or treatment. Patients who have DFUs, or are at risk of developing DFUs, should consult with a qualified healthcare provider.
Product availability and labelling will vary by region and is subject to regulatory clearance or approval. As these products are not yet commercially available, Instructions for Use (IFU) and related clinical documentation are not published on this website. These materials will be made available in accordance with applicable regulatory requirements upon commercial launch.
